You are here: Home » News-IANS » Health-Medicine
Business Standard

New single dose experimental Ebola drug effective: Study

IANS  |  New York 

Scientists have developed an experimental new drug that can in a single dose successfully protect non-human primates against a lethal of all strains of the deadly

"Our experimental drug can protect against all forms of known to harm people, suggesting that it will continue to protect people if the viruses evolve over time," said Thomas Geisbert, at The University of

In the study, reported in the journal Cell Host and Microbe, the team demonstrated that a two-antibody cocktail called MBP134 could fully protect non-human primates and ferrets against lethal infections caused by the Bundibugyo and strain.

It was also found effective against the deadliest Zaire strain that caused the 2013-16 epidemic in and the current outbreak in the

"We were able to protect the non-human primates against all the Ebola species plaguing people at a single low dose," said Larry Zeitlin, of -- a US-based company.

According to Geisbert, previous therapeutics typically were of the "one bug, one drug" variety.

But because of the unpredictable nature and variety of the Ebola virus, scientists have been seeking a way to protect against different strains of the

"The ability to quickly and efficiently provide protection against all Ebola viruses in a single dose would reduce the burden on care workers in the field during outbreaks, especially in regions that have a less-developed infrastructure," Zeitlin said.

"Further studies exploring even lower doses could open the door to treatment via auto-injectors like the kind used for allergic reactions," he noted.



(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, January 10 2019. 19:10 IST